{"entity":{"id":"nct07539155","kind":"trial","name":"Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer","aka":[],"tldr":"A phase 1/2 trial in pancreatic cancer, run by University of Arkansas, now recruiting.","summary":"Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer is a phase 1/2, interventional study registered as NCT07539155 by University of Arkansas, with a registry enrolment figure of 20 participants, started 2026-06-26 and due to reach its primary completion in 2028-08. Interventions recorded: Intratumoral MMR Injection. Conditions listed: Borderline Resectable/Unresectable Pancreatic Cancer; Non Metastatic Pancreatic Cancer. Primary outcome: Intratumoral T-Cell Response. Pancreatic eligibility wording from the registry: \"Pathologically proven locally advanced adenocarcinoma of pancreas\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07539155","url":"https://clinicaltrials.gov/study/NCT07539155"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["borderline-resectable-pdac","locally-advanced-pdac","metastatic-pdac"],"sections":[],"technologies":["shared-antigen-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07539155","phase":"1/2","setting":"Phase 1b/2 Study of Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer","sponsor":"University of Arkansas","enrolled":20,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07539155/","neighbours":{"cancer":[{"id":"borderline-resectable-pdac","kind":"cancer","name":"Borderline resectable pancreatic ductal adenocarcinoma","route":"/cancers/borderline-resectable-pdac/"},{"id":"locally-advanced-pdac","kind":"cancer","name":"Locally advanced unresectable pancreatic ductal adenocarcinoma","route":"/cancers/locally-advanced-pdac/"},{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"technology":[{"id":"shared-antigen-vaccine","kind":"technology","name":"Off-the-shelf cancer vaccines","route":"/technologies/shared-antigen-vaccine/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}